FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Fibrillin-1 (FBN1) is a key structural protein forming microfibrils in connective tissues.
• FBN1 mutations cause Marfan syndrome, characterized by tall stature, arachnodactyly, ectopia lentis, and aortic aneurysms.
• Conversely, specific FBN1 mutations are linked to Weill-Marchesani syndrome, causing short stature and brachydactyly.

Purpose of the Study:

• To explore the molecular mechanisms underlying the divergent clinical presentations of fibrillinopathies.
• To elucidate how mutations in a single gene, FBN1, lead to opposing phenotypic outcomes.

Main Methods:

• Review of current literature on FBN1 mutations and associated syndromes.
• Analysis of genotype-phenotype correlations in Marfan syndrome and related disorders.
• Exploration of the role of tissue-specific microenvironments and growth factor signaling.

Main Results:

• Over a thousand FBN1 mutations are identified, complicating direct genotype-phenotype correlations.
• Distinct mutations in FBN1 can result in either Marfan syndrome or Weill-Marchesani syndrome.
• Tissue-specific fibrillin microfibril microenvironments are crucial for understanding these disparate outcomes.

Conclusions:

• The diverse clinical manifestations of fibrillinopathies are influenced by tissue-specific fibrillin microfibril structures.
• The interplay between fibrillin microfibril networks and growth factor signaling pathways explains the opposing phenotypes.
• A comprehensive understanding of fibrillinopathies necessitates considering the broader biological context beyond the FBN1 gene itself.